|
End-of-day quote
LUXEMBOURG S.E.
05/10/2026
|
5-day change | 1st Jan Change | ||
| 13.90 USD | -0.71% |
|
-4.79% | -17.26% |
| 09-22 | Cipla Limited and Cipla Usa Inc. Announces Management Changes, Effective October 1, 2026 | CI |
| 09-03 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Cipla Limited(CIPLA)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Cipla Limited(CIPLA)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Cipla Limited(CIPLA)
EBIT
Dividend / Share (DPS)
Data source:
Cipla Limited(CIPLA)
Cash or Net Debt
- Stock Market
- Stocks
- CIPLA Stock
- CIPLA Stock
- Consensus Cipla Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
